GL1X · GenesisL1 explorer

MolNFT v1 · #147085 · protein

Discovery of potent 2-aryl-6,7-dihydro-5HPYRROLO[ 1,2-A]IMIDAZOLES as WDR5 win-site inhibitors using fragment-based methods and structure- based design

6E1Y · Wd repeat-containing protein 5: “Discovery of potent 2-aryl-6,7-dihydro-5HPYRROLO[ 1,2-A]IMIDAZOLES as WDR5 win-site inhibitors using…”. X-ray diffraction, 1 ligand (HLM), 4 pockets (best druggability 0.77). MolNFT v1 #147085 on…

PDB
6E1Y
Type
protein
Length
600 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Wd repeat-containing protein 5
UniProt
P61964
Ligands
HLM
Pockets
4 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 0% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AWd repeat-containing protein 5protein2990% helix, 52% strandP61964
BWd repeat-containing protein 5protein3010% helix, 52% strandP61964

Ligands and binding sites

  • HLM · N-[(1S)-1-(3-chlorophenyl)ethyl]-3-{[(4,5-dihydro-1H-imidazol-2-yl)amino]methyl}benzamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111060.770.7994HLM
26730.750.8171HLM
3660.400.8015empty
4530.350.7813empty

Interfaces

1 interface between chains.

  • A–B · 148 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 6E1Y · Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.